As of 2026-03-13, the Relative Valuation of Ramm Pharma Corp (RAMM.CN) is (0.16) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.02 CAD, the upside of Ramm Pharma Corp based on Relative Valuation is -1175.4%.
The range of the Relative Valuation is (0.08) - (0.21) CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 1.1x - 4.6x | 2.8x |
| Forward P/E multiples | 0.8x - 3.2x | 2.0x |
| Fair Price | (0.08) - (0.21) | (0.16) |
| Upside | -605.5% - -1519.0% | -1175.4% |
| Date | P/E |
| 2026-03-09 | -0.23 |
| 2026-03-04 | -0.30 |
| 2026-02-27 | -0.30 |
| 2026-02-23 | -0.38 |
| 2026-02-19 | -0.30 |
| 2026-02-17 | -0.38 |
| 2026-02-10 | -0.38 |
| 2026-02-09 | -0.38 |
| 2026-02-05 | -0.45 |
| 2026-02-04 | -0.53 |
| 2026-02-03 | -0.53 |
| 2026-01-28 | -0.45 |
| 2026-01-19 | -0.53 |
| 2026-01-14 | -0.60 |
| 2026-01-12 | -0.60 |
| 2026-01-05 | -0.60 |
| 2025-12-31 | -0.90 |
| 2025-12-30 | -0.83 |
| 2025-12-29 | -0.75 |
| 2025-12-22 | -0.60 |
| 2025-12-19 | -0.60 |
| 2025-12-18 | -0.75 |
| 2025-12-17 | -0.75 |
| 2025-12-16 | -0.60 |
| 2025-12-15 | -0.38 |